Clinics of Oncology
About Us
Author Guidelines
Contact
Editor in Chief
Editorial Board
Home
Peer Review Process
Submit Manuscript
Terms & Conditions
Volumes
Melphalan, Dexametasone and Thalidomide, Autoloogous Stem Cell and Maintenance withLow Doses of Thalidomide
Apr 5, 2024
—
by
in
Volume 6
Case Report
←
Previous:
Granulocyte Colony-Stimulating Factor in Adults with Solid Tumors – Need forImplementing Guidelines
Next:
Crosstalk Involved in Liver Inflammation and Hepatocellular Carcinoma
→
error:
Content is protected !!